2C32.1

ICD-11 MMS 2026-01

Sclerosing basal cell carcinoma of skin

Description

This form of basal cell carcinoma is composed of thin strands, cords and columns of malignant cells which infiltrate between collagen bundles of the dermis. It may infiltrate widely and deeply before it becomes clinically obvious. It typically starts as a pale, poorly-defined indurated plaque which may not come to medical attention until it starts to bleed and crust.

Coding note from above levels

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Index terms

  • Sclerosing basal cell carcinoma of skin
  • Cicatrising basal call carcinoma
  • Morpheaform basal cell carcinoma of skin
Show allHide
  • Morphoeic basal cell carcinoma of skin
  • morphea basal cell carcinoma of unspecified site

Exclusions from above levels

  • 2E08 – Malignant neoplasm metastasis in skin
  • 2E64 – Carcinoma in situ of skin
  • http://id.who.int/icd/entity/1965082709 – Malignant mesenchymal neoplasms
Show allHide
  • http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
  • http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Sibling codes

  • 2C32.0 – Nodular basal cell carcinoma of skin
  • 2C32.2 – Superficial basal cell carcinoma of skin
  • 2C32.Y – Other specified basal cell carcinoma of skin
  • 2C32.Z – Basal cell carcinoma of skin, unspecified

Foundation entity

Sclerosing basal cell carcinoma of skin – http://id.who.int/icd/entity/138464905

Allowed postcoordination axes

Part of: 2C32: Basal cell carcinoma of skin › 02: Neoplasms